Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_assertion type Assertion NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_head.
- NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_assertion description "[Significant new developments in eukaryotic glycogen metabolism over the last decade or so include: (i) three-dimensional structures of the biosynthetic enzymes glycogenin and glycogen synthase, with associated implications for mechanism and control; (ii) analyses of several genetically engineered mice with altered glycogen metabolism that shed light on the mechanism of control; (iii) greater appreciation of the spatial aspects of glycogen metabolism, including more focus on the lysosomal degradation of glycogen; and (iv) glycogen phosphorylation and advances in the study of Lafora disease, which is emerging as a glycogen storage disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_provenance.
- NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_assertion evidence source_evidence_literature NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_provenance.
- NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_assertion SIO_000772 22248338 NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_provenance.
- NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_assertion wasDerivedFrom befree-20150227 NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_provenance.
- NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_assertion wasGeneratedBy ECO_0000203 NP442315.RA_Z1zk1Q6iVtHICXZ35t3ooHs6zThgSZMGgckO80aZ6s130_provenance.